Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Advances in Pharmacology (San Diego, Calif.)|July 11, 2012
Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological interventionEdith Sim, Giannoulis Fakis, Nicola Laurieri, et al.Scientific Reports|June 1, 2016
Treatment of Rats with Apocynin Has Considerable Inhibitory Effects on Arylamine N-Acetyltransferase Activity in the LiverSheena Francis, Nicola Laurieri, Chukwuemeka Nwokocha, et al.Scientific Reports|February 23, 2012
Activation of nitrofurazone by azoreductases: multiple activities in one enzymeAli Ryan, Elise Kaplan, Nicola Laurieri, et al.Protein & Cell|January 5, 2011
Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductasesAli Ryan, Chan-Ju Wang, Nicola Laurieri, et al.Journal of the Royal Society, Interface|July 10, 2009
Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferasesPedro J Ballester, Isaac Westwood, Nicola Laurieri, et al.Pharmacogenomics|August 17, 2011
Pharmacogenomics, biochemistry, toxicology, microbiology and cancer research in one goFernando Rodrigues-Lima, Julien Dairou, Nicola Laurieri, et al.Journal of Molecular Biology|April 27, 2010
A novel mechanism for azoreductionAli Ryan, Nicola Laurieri, Isaac Westwood, et al.Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|January 9, 2010
Role of tyrosine 131 in the active site of paAzoR1, an azoreductase with specificity for the inflammatory bowel disease prodrug balsalazideChan-Ju Wang, Nicola Laurieri, Areej Abuhammad, et al.Fitoterapia|July 9, 2018
Chemical composition and biological activities of the essential oil from Cleome rutidosperma DCMegil J McNeil, Roy B R Porter, Lois Rainford, et al.BMC Pharmacology & Toxicology|November 30, 2014
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor bindingNicola Laurieri, Akane Kawamura, Isaac M Westwood, et al.Pageof 2